BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25431764)

  • 1. Heat shock protein 70 in Alzheimer's disease.
    Lu RC; Tan MS; Wang H; Xie AM; Yu JT; Tan L
    Biomed Res Int; 2014; 2014():435203. PubMed ID: 25431764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock proteins at the crossroads between cancer and Alzheimer's disease.
    Wang H; Tan MS; Lu RC; Yu JT; Tan L
    Biomed Res Int; 2014; 2014():239164. PubMed ID: 25147790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting.
    Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 90 in Alzheimer's disease.
    Ou JR; Tan MS; Xie AM; Yu JT; Tan L
    Biomed Res Int; 2014; 2014():796869. PubMed ID: 25374890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 70 and tumor necrosis factor alpha in Taiwanese patients with dementia.
    Fung HC; Chen CM; Wu YR; Hsu WC; Ro LS; Lin JC; Chang KH; Wang HK; Lin SJ; Chan H; Lin YY; Wei SL; Hsu Y; Hwang JC; Tung LC; Lee-Chen GJ
    Dement Geriatr Cogn Disord; 2005; 20(1):1-7. PubMed ID: 15832029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nucleolus as a Proteostasis Regulator.
    Amer-Sarsour F; Ashkenazi A
    Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
    Repalli J; Meruelo D
    Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
    Scannevin RH
    Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
    Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
    Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer's disease.
    Clarimón J; Bertranpetit J; Boada M; Tàrraga L; Comas D
    J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):146-50. PubMed ID: 12967056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease.
    Dong Y; Li T; Ma Z; Zhou C; Wang X; Li J
    Dis Markers; 2022; 2022():9480398. PubMed ID: 36246562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases.
    Sonninen TM; Goldsteins G; Laham-Karam N; Koistinaho J; Lehtonen Š
    Cells; 2020 Sep; 9(10):. PubMed ID: 32998318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HSPA8 and HSPA9 mRNA expression and promoter methylation in the brain and blood of Alzheimer's disease patients.
    Silva PN; Furuya TK; Braga IL; Rasmussen LT; Labio RW; Bertolucci PH; Chen ES; Turecki G; Mechawar N; Payão SL; Mill J; Smith MC
    J Alzheimers Dis; 2014; 38(1):165-70. PubMed ID: 23948933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of heat shock proteins in Parkinson's disease.
    Aridon P; Geraci F; Turturici G; D'Amelio M; Savettieri G; Sconzo G
    Neurodegener Dis; 2011; 8(4):155-68. PubMed ID: 21212626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of exogenous hsp70 in mouse models of Alzheimer's disease.
    Bobkova NV; Garbuz DG; Nesterova I; Medvinskaya N; Samokhin A; Alexandrova I; Yashin V; Karpov V; Kukharsky MS; Ninkina NN; Smirnov AA; Nudler E; Evgen'ev M
    J Alzheimers Dis; 2014; 38(2):425-35. PubMed ID: 23985416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel mouse model of enhanced proteostasis: Full-length human heat shock factor 1 transgenic mice.
    Pierce A; Wei R; Halade D; Yoo SE; Ran Q; Richardson A
    Biochem Biophys Res Commun; 2010 Nov; 402(1):59-65. PubMed ID: 20920476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.